Quantcast

Latest Cetuximab Stories

2013-12-18 09:46:31

The epidermal growth factor receptor (EGFR) is expressed in normal colonic cells and is activated by specific peptide growth factors that regulate cell proliferation, survival and differentiation. Increased expression and activation of the EGFR has been observed in the majority of colorectal carcinoma (CRC), suggesting that the EGFR pathway plays an important role in colon carcinogenesis. The monoclonal antibodies cetuximab and panitumumab are capable of blocking EGFR activity and have...

2013-12-12 23:00:14

ResearchMoz.us include new market research report "Monoclonal Antibodies Market in Colorectal Cancer to 2019" to its huge collection of research reports. Click here to download detail report at http://www.researchmoz.us/monoclonal-antibodies-market-in-colorectal-cancer-to-2019-favorable-pricing-policy-in-the-us-and-rising-prevalence-in-europe-and-japan-ensures-market-growth-report.html. Albany, New York (PRWEB) December 13, 2013 GBI Research, has released the pharma report -...

2013-10-21 10:08:34

Patients with cancers driven by the protein KRAS, which are particularly hard to treat, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23. Mutant forms of the protein KRAS are found in approximately 30 percent of all cancers. They are responsible for many of the hallmarks of these...

2013-09-30 14:06:50

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalized medicine to patients across Europe, says the European Society for Medical Oncology. It has become clear in recent years that each patient's cancer has individual characteristics that are potentially amenable to "personalized" treatments that target those characteristics. But there is still a great deal of...

2013-09-30 13:54:55

Improves treatment and survival Identifying the molecular profile of a tumor where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013), will hear on Monday. In up to five percent of all cancers, the site of the primary tumor is unknown and the disease is not diagnosed until it is at an advanced stage, when the cancer has metastasized (spread to other parts of the body). Until recently, the choice of treatment has been based on...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.